NCT06249711

Brief Summary

This study will evaluate a new form of non-invasive deep brain therapy for food addiction. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled trial. The trial will evaluate brain target engagement using magnetic resonance imaging, Food Cravings Questionnaire-State, and changes in subject's weight over the course of the study.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

March 3, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2024

Completed
Last Updated

May 22, 2025

Status Verified

April 1, 2025

Enrollment Period

Same day

First QC Date

January 31, 2024

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in body weight (%) from baseline week 0 to week 16

    The body weight will be quantified with respect to baseline (100%), taken prior to the first intervention.

    The body weight will be taken prior to each intervention (once per week)

  • Number of participants who achieved body weight reduction >= 5%

    Proportion of subjects who have lost at least 5% of their weight at week 16 relative to the baseline week 0.

    Assessment at week 16

  • Food Cravings Questionnaire-State

    This 15-item questionnaire measures immediate level of food craving, each item ranging from 1 (strongly disagree) to 5 (strongly agree). Higher total scores indicate stronger desire to eat.

    During and immediately after each weekly intervention

  • Hamilton Depression Rating Scale, 17 item

    This 17-item questionnaire measures the severity of depression. Scores range between 0 (least severe) to 52 (most severe).

    For up to 16 weeks

Study Arms (2)

Active stimulation

ACTIVE COMPARATOR

Low-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction

Device: Active stimulation with Diadem ultrasonic transducer array

Sham stimulation

SHAM COMPARATOR

Zero-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction

Device: Sham stimulation with Diadem ultrasonic transducer array

Interventions

Diadem ultrasonic transducer array delivers focused low-intensity ultrasound stimulation

Active stimulation

Diadem ultrasonic transducer array delivers focused zero-intensity ultrasound stimulation

Sham stimulation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of at least one self-reported unsuccessful dietary effort to lose body weight
  • Body mass index more than or equal to 30 kg/m\^2 or more than or equal to 25 kg/m\^2 with the presence of at least one of the following weight-related comorbidities: hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease.

You may not qualify if:

  • Lifetime history of a serious suicide attempt
  • MRI intolerance or contraindication
  • Pregnant or breast feeding
  • Diabetic (HbA1c more than 48 mmol/mol or 6.5%)
  • A self-reported change in body weight more than 10 lbs within 60 days before screening
  • Clinically inappropriate for participation in the study as determined by the study team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84103, United States

Location

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jan Kubanek, PhD

    University of Utah

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

March 3, 2024

Primary Completion

March 3, 2024

Study Completion

March 3, 2024

Last Updated

May 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations